Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | N/A | 137,070 | 137,070 |
| Other current assets | 0 | 0 | 5,410 | 5,410 | 5,412 |
| TOTAL | $0 | $0 | $5,410 | $142,480 | $142,482 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 7,700 | 6,180 |
| TOTAL | $N/A | $N/A | $N/A | $7,700 | $6,180 |
| Total Assets | $0 | $0 | $5,410 | $148,660 | $148,662 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,940 | 0 |
| Accrued Expenses | 0 | 0 | N/A | 3,080 | N/A |
| TOTAL | $0 | $0 | $N/A | $5,030 | $5,033 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 760 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $1,020 | $N/A |
| Total Liabilities | $0 | $0 | $N/A | $6,060 | $6,061 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | N/A | 1 | N/A |
| Retained earnings | 0 | 0 | N/A | -47,900 | -47,902 |
| Other shareholders' equity | 0 | 0 | -3,840 | -3,851 | 190,503 |
| TOTAL | $0 | $0 | $-3,840 | $142,600 | $142,601 |
| Total Liabilities And Equity | $0 | $0 | $-3,840 | $148,660 | $148,662 |